… As such, in-depth discussion has not been included in this article and will be covered …
registry that allowed inclusion of longer lesions, instent restenosis, and lesions as far distal as the …

… from a registry comparing paclitaxel-eluting stents with PCBs in long lesions, with a mean
lesion length of 19 cm in both groups. Primary paclitaxel-eluting stenting was associated with a …

… -eluting stents with PCBs in long lesions, with a mean lesion length of 19 cm … covered stent
with bare metal stents, showed a primary patency rate of 71.3% at 1 year for TASC D lesions (…

… covered stent implantation, drug-coated balloon (DCB), and directional atherectomy (DA; the
heparin-bonded covered stent… In our study, the target lesion was limited to the proximal SFA …

… lesions, we have adopted 3 different approaches to stenting: … coated balloons are the
best in reducing restenosis in small vessels. However, not all lesions can be treated by drug-coated …

… -coated balloon (DCB), angioplasty with optional bailout stenting, and primary stenting using
a covered stent (… treatment modalities for de novo SFA lesions when inclusion criteria were …

… polytetrafluoroethylene (ePTFE) covered stent (Viabahn, WL … in long SFA stenotic or occlusive
lesions (TASC C and D lesions) … or covered stent deployment to the target SFA lesion with …

… stents (BMS), covered stents (CS), and drug-eluting stents (DES) for long-segment … SFA
lesions measuring at least 15 cm in length who successfully received an endovascular stent (…

… (>15 cm), TASC C and D 14 SFA lesions (the heparin-bonded Viabahn was unavailable in
… with dissected SFA lesions and any previous SFA intervention (eg, angioplasty, stenting, or …

… data on long sfa lesions and supera stenting is mainly based … lesions >15 cm with 53%
CTOs and 52% of the SFA lesions … (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver …